ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 670802 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 670802; 2) Community: the network communities that were significantly associated with the response to NSC 670802; 3) Molecule: the relationships between components within communities and NSC 670802; 4) MDR: the compounds that were significantly associated with the NSC 670802.

NSC Compound Enrichment Correlation
NSC 740387 1N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-[4-(3-{4-(3-(4-flu orophenyl)-3-oxo-(E)-1-propenyl]-2-methoxyphenoxy}propyl)hex ahydro-1-pyrazinyl]acetamide 0.0228506033927957 0.36632793
NSC 743413 N-(4-Methoxyphenyl)-all-trans-retinamide 0.0228506033927957 0.40569994
NSC 748904 [(20S)-20-(N,N-dimethylamino)-5a-preg-3a-aminal], N-formylchonemorphine 0.0228506033927957 0.19267636
NSC 755443 Null 0.0228506033927957 0.075763919
NSC 761769 Null 0.0228506033927957 0.44074518
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0235234559682125 -0.13875194
NSC 321240 Null 0.0235234559682125 0.30181773
NSC 335995 Null 0.0235234559682125 0.24885733
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0235234559682125 0.51631544
NSC 55236 Null 0.0235234559682125 0.38539388
Total:67  Current:34    [First] [Prev] [Next] [Last]